ACUTE LYMPHOCYTIC LEUKEMIA
Clinical trials for ACUTE LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to stop deadly transplant complication
Disease control Not yet recruitingThis study tests a drug called ivarmacitinib to prevent acute graft-versus-host disease (aGVHD) in 32 people with blood cancers receiving a half-matched stem cell transplant. The goal is to see if the drug can lower the chance of severe GVHD and improve survival without long-term…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New shot targets leukemia that chemo Can't beat
Disease control Not yet recruitingThis study tests an experimental antibody drug called A-319 for people with a type of leukemia (B-ALL) that has come back or not fully cleared after chemotherapy. The drug is given as a shot under the skin and aims to help the immune system attack cancer cells. The main goals are…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: NA • Sponsor: Shanxi Bethune Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC